Affiliation:
1. Renal Unit, Algemeen Ziekenhuis St. Jan, Brugge, Belgium.
Abstract
The single-dose pharmacokinetics of 200 mg of oral itraconazole were studied in seven uremic patients, seven patients treated by hemodialysis, and five patients treated by continuous ambulatory peritoneal dialysis. Plasma concentration-versus-time profiles showed wide intersubject variation. This study could not demonstrate any significant effect of renal dysfunction and hemodialysis or continuous ambulatory peritoneal dialysis treatment upon the pharmacokinetics of itraconazole, and firm conclusions concerning dosing in such patients should await confirmation of our data in a larger patient population.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference7 articles.
1. Gibaldi M. and D. Perrier. 1982. Pharmacokinetics 2nd ed. Marcel Dekker Inc. New York.
2. Pharmacokinetics of itraconazole following oral administration to normal volunteers;Hardin T. C.;Antimicrob. Agents Chemother.,1988
3. Heykants J. M. Michiels W. Meuldermans J. Monbaliu K. Lavrijsen A. Van Peer J. C. Levron R. Woestenborghs and G. Cauwenbergh. 1987. The pharmacokinetics of itraconazole in animals and man: an overview p. 223-249. In R. A. Fromtling (ed.) Recent trends in the discovery development and evaluation of antifungal agents. J. R. Prous Science Publishers Barcelona Spain.
4. Meuldermans W. and J. Heykants. 1986. The plasma protein binding of itraconazole and its distribution in blood. Preclinical Research Report R 51211/33. Janssen Pharmaceutica Beerse Belgium.
5. Azole antifungal agents: emphasis on new triazoles;Saag M. S.;Antimicrob. Agents Chemother.,1988
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献